ADAM17 and hepatocellular carcinoma: For instance, in cases of hepatocellular carcinoma (HCC), miR-145 was found to inhibit ADAM17 (A disintegrin and metalloproteinase 17), consequently inhibiting cell proliferation and growth in liver cancer cells [160].